187,565 Shares in Carmell Co. (NASDAQ:CTCX) Bought by Citadel Advisors LLC

Citadel Advisors LLC acquired a new position in Carmell Co. (NASDAQ:CTCX) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 187,565 shares of the company’s stock, valued at approximately $54,000.

Separately, Antara Capital LP purchased a new stake in shares of Carmell in the 4th quarter worth about $28,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Carmell Price Performance

Shares of NASDAQ CTCX opened at $2.68 on Thursday. Carmell Co. has a 1 year low of $0.17 and a 1 year high of $2.33. The firm has a 50-day moving average of $1.29 and a 200 day moving average of $0.64.

Carmell Profile

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.